Literature DB >> 15532988

Genome-based vaccines.

Andreas Knaust1, Matthias Frosch.   

Abstract

Vaccination is an effective possibility to prevent many bacterial or viral infections, but for several important pathogens still no vaccines are available. The sequences of complete genomes are now decoded for an increasing number of bacterial pathogens and offer the possibility for comprehensive screenings to identify targets for vaccine development. In this article current genomic approaches to identify antigenic proteins of Neisseria meningitidis, Streptococcus pneumoniae, Staphylococcus aureus, and Chlamydia pneumoniae are summarized.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15532988     DOI: 10.1016/j.ijmm.2004.07.008

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  4 in total

1.  Enhanced protection against nasopharyngeal carriage of Streptococcus pneumoniae elicited by oral multiantigen DNA vaccines delivered in attenuated Salmonella typhimurium.

Authors:  Qiao Zhang; Qianli Ma; Qi Li; Wei Yao; Changzheng Wang
Journal:  Mol Biol Rep       Date:  2010-06-19       Impact factor: 2.316

2.  Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins.

Authors:  Jyotika Sharma; Youmin Zhong; Feng Dong; Jeanna M Piper; Guqi Wang; Guangming Zhong
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

3.  Identification and experimental verification of protective antigens against Streptococcus suis serotype 2 based on genome sequence analysis.

Authors:  Lina Liu; Gong Cheng; Changjun Wang; Xiuzhen Pan; Yanguang Cong; Qu Pan; Jing Wang; Feng Zheng; Fuquan Hu; Jiaqi Tang
Journal:  Curr Microbiol       Date:  2008-10-07       Impact factor: 2.188

4.  Coping with genetic diversity: the contribution of pathogen and human genomics to modern vaccinology.

Authors:  D Lemaire; T Barbosa; P Rihet
Journal:  Braz J Med Biol Res       Date:  2011-10-28       Impact factor: 2.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.